All posts by: Michael Zand

About Michael Zand

Flaws in a tumor’s genetic mending kit drive treatment response to immunotherapy – Science Daily

Continue reading

2017-06-11 NEWS

Science Daily

Flaws in a tumor’s genetic mending kit drive treatment response to immunotherapy
Science Daily
In an expanded, three-year clinical trial of 86 patients with colorectal and 11 other kinds of cancer that have so-called ‘mismatch repair’ genetic defects, scientists at Johns Hopkins Medicine and its Bloomberg~Kimmel Institute for Cancer

Continue reading

2017-06-11 NEWS

Science Daily

Flaws in a tumor’s genetic mending kit drive treatment response to immunotherapy
Science Daily
In an expanded, three-year clinical trial of 86 patients with colorectal and 11 other kinds of cancer that have so-called ‘mismatch repair’ genetic defects, scientists at Johns Hopkins Medicine and its Bloomberg~Kimmel Institute for Cancer

Continue reading

2017-06-11 NEWS

Healthline

Is CRISPR Gene Editing Moving Ahead Too Quickly?
Healthline
CRISPR-Cas9 was discovered in 2012 by University of California molecular biologist Jennifer Doudna and her colleagues. It allows for genetic “editing” by snipping out small bits of defective or harmful DNA and replacing it. Gene editing has existed

Continue reading

2017-06-11 NEWS

Healthline

Is CRISPR Gene Editing Moving Ahead Too Quickly?
Healthline
CRISPR-Cas9 was discovered in 2012 by University of California molecular biologist Jennifer Doudna and her colleagues. It allows for genetic “editing” by snipping out small bits of defective or harmful DNA and replacing it. Gene editing has existed